Author:
Sié P.,Samama C.-M.,Godier A.,Rosencher N.,Steib A.,Llau J.-V.,van der Linden P.,Pernod G.,Lecompte T.,Gouin-Thibault I.,Albaladejo P.
Subject
Anesthesiology and Pain Medicine,General Medicine
Reference26 articles.
1. Oral rivaroxaban for symptomatic venous thromboembolism;Bauersachs;N Engl J Med.,2010
2. Dabigatran versus warfarin in the treatment of acute venous thromboembolism;Schulman;N Engl J Med.,2009
3. Mahaffey KW, Fox KAA, on behalf of the ROCKET AF Investigators. Rivaroxaban once-daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation. American Heart Association Scientific Session. Chicago 13-15 novembre 2010.
4. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med.,2009
5. Once daily oral rivaroxaban versus placebo in the long term prevention of recurrent symptomatic venous thromboembolism. The Einstein-Extension study;Buller;Blood.,2009
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献